Endogenex Receives IDE Approval to Initiate Pivotal Clinical Study
January 30, 2024
A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of the ReCET™ System in Adult Patients with Type 2 Diabetes
A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of the ReCET™ System in Adult Patients with Type 2 Diabetes
Element Science announced that it received CE mark approval for its novel patch-wearable cardioverter defibrillator (P-WCD).
The single-use, PEEK-based RIB System utilizes the platform technology of Able’s Valkyrie® Thoracic Fixation System, further strengthening Able Medical’s portfolio.
Intuitive Surgical (Nasdaq: ISRG)+
announced today that it received CE mark approval for its da Vinci SP surgical robot platform.
Zoll this week announced it received FDA clearance and CE mark approval for upgrades to its Thermogard temperature management system
Pulse Biosciences (Nasdaq:PLSE) today announced the
The clearance positions BD and partner Babson Diagnostics to support blood collection from community sites such as pharmacies.
LivaNova (NASDAQ: LIVN)+
says it’s the latest victim of a cybersecurity incident.
FORT MILL, SC / ACCESSWIRE / November 20, 2023 / Catheter Precision, Inc. (the “Company”) (NYSE American:VTAK), a pioneering medical technology firm headquartered in the United States, specializing in electrophysiology devices, has proudly disclosed the successful conclusion of the inaugural VIVO cases in the region of South-Eastern Europe. VIVO, the Company’s innovative 3D non-invasive imaging system, is used pre-procedurally to identify areas of interest for ventricular ablation and aid in pre-procedure planning to reduce procedure time and aid in procedural accuracy.
The first U.S. commercial cases have been completed with the Abbott (NYSE: ABT)+
Aveir dual-chamber leadless pacemaker technology.